organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 65| Part 12| December 2009| Pages o3249-o3250

5-Meth­oxy­methyl-4-phen­­oxy-1H-pyrazol-3-ol

aX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, and bOrganic Chemistry Division, School of Advanced Sciences, VIT University, Vellore 632 014, India
*Correspondence e-mail: hkfun@usm.my

(Received 18 November 2009; accepted 23 November 2009; online 28 November 2009)

In the title compound, C11H12N2O3, the pyrazole ring system is essentially planar [maximum deviation = 0.002 (2) Å] and forms a dihedral angle of 66.93 (9)° with the benzene ring. In the crystal packing, pairs of inter­molecular N—H⋯O and O—H⋯N hydrogen bonds connect neighbouring mol­ecules into dimers, generating R22(10) and R22(8) ring motifs, respectively. The crystal structure is further stabilized by C—H⋯π inter­actions.

Related literature

For the biological activity of pyrazoles, see: Genin et al. (2000[Genin, M. J., Biles, C., Keiser, B. J., Poppe, S. M., Swaney, S. M., Tarpley, W. G., Yagi, Y. & Romero, D. L. (2000). J. Med. Chem. 43, 1034-1040.]); Hsu et al. (1956[Hsu, T. C., Robins, R. K. & Cheng, C. C. (1956). Science, 13, 848-868.]); Jung et al. (2002[Jung, J. C., Walkins, E. B. & Avery, M. A. (2002). Tetrahedron, 58, 3039-3049.]); Kudo et al. (1999[Kudo, N., Furuta, S., Taniguchi, M., Endo, T. & Sato, K. (1999). Chem. Pharm. Bull. 47, 857-868.]); Singh et al. (1978[Singh, S. P., Prakash, O., Tomer, R. K. & Sawhney, S. N. (1978). Indian J. Chem. Sect. B, 16, 733-735.]); Skipper et al. (1955[Skipper, H. E., Robins, R. K. & Thompson, J. R. (1955). Proc. Soc. Exp. Bio. Med. 89, 589-594.]); Storer et al. (1999[Storer, R., Ashton, C. J., Baxter, A. D., Hann, M. M., Marr, C. L. P., Mason, A. M., Mo, C. L., Myers, P. L., Noble, S. A., Penn, H. R., Weir, N. G., Niall, G., Woods, J. M. & Coe, P. L. (1999). Nucleosides Nucleotides, 18, 203-216.]); Tewari & Mishra (2001[Tewari, A. K. & Mishra, A. (2001). Bioorg. Med. Chem. 9, 715-718.]). For pyrazole derivatives, see: Baraldi et al. (2003[Baraldi, P. G., Bovero, A., Fruttarolo, F., Romagnoli, R., Tabrizi, M. A., Preti, D., Varani, K., Borea, P. A. & Moorman, A. R. (2003). Bioorg. Med. Chem. 11, 4161-4169.]); Brown et al. (2004[Brown, M. L., Cheung, M., Dickerson, S. H., Drewy, D. H., Lackey, K. E., Peat, A. J., Thomson, S. A., Veal, J. M. & Wilson, J. L. R. (2004). PCT Int. Appl. WO 20049596.]); Duma et al. (2000[Duma, J., Hatoum-Mokdad, H., Sibley, R., Riedl, B., Scott, W. J., Monahan, M. K., Lowinger, T. B., Brennan, C., Natero, R., Turner, T., Johnson, J. S., Schoenlebar, R., Bhargava, A., Wilhelm, S. M., Housley, T. J., Ranges, G. E. & Shrikhande, A. (2000). Bioorg. Med. Chem. Lett. 10, 2051-2054.]); Heerding (2003[Heerding, D. A. (2003). PCT Int. Appl. WO, 2003103686.]); Qiao et al. (2003[Qiao, J. X., Pinto, D. J., Orwat, M. J., Han, W. & Friedrich, S. R. (2003). PCT Int. Appl. WO, 200399276.]); Stamford & Wu (2004[Stamford, A. W. & Wu, Y. (2004). PCT Int. Appl. WO 20045262.]). For a related structure, see: Goh et al. (2009[Goh, J. H., Fun, H.-K., Nithinchandra, & Kalluraya, B. (2009). Acta Cryst. E65, o3088-o3089.]). For hydrogen-bond motifs, see: Bernstein et al. (1995[Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.]). For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986[Cosier, J. & Glazer, A. M. (1986). J. Appl. Cryst. 19, 105-107.]).

[Scheme 1]

Experimental

Crystal data
  • C11H12N2O3

  • Mr = 220.23

  • Monoclinic, P 21 /c

  • a = 8.8876 (5) Å

  • b = 10.3031 (5) Å

  • c = 12.0083 (6) Å

  • β = 100.917 (3)°

  • V = 1079.7 (1) Å3

  • Z = 4

  • Mo Kα radiation

  • μ = 0.10 mm−1

  • T = 100 K

  • 0.69 × 0.57 × 0.18 mm

Data collection
  • Bruker SMART APEXII CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wiscosin, USA.]) Tmin = 0.934, Tmax = 0.983

  • 14470 measured reflections

  • 3433 independent reflections

  • 2373 reflections with I > 2σ(I)

  • Rint = 0.032

Refinement
  • R[F2 > 2σ(F2)] = 0.058

  • wR(F2) = 0.138

  • S = 1.10

  • 3433 reflections

  • 193 parameters

  • All H-atom parameters refined

  • Δρmax = 0.45 e Å−3

  • Δρmin = −0.33 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A DA D—H⋯A
N2—H1N2⋯O2i 0.91 (2) 1.89 (2) 2.7778 (18) 165.7 (19)
O3—H1O3⋯N1ii 0.92 (2) 1.74 (2) 2.6663 (18) 176 (2)
C3—H3ACg1iii 0.94 (2) 2.77 (3) 2.73 147.6 (18)
Symmetry codes: (i) -x+2, -y+1, -z; (ii) -x+2, -y, -z; (iii) x-1, y, z. Cg1 is the centroid of the C1–C6 benzene ring.

Data collection: APEX2 (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wiscosin, USA.]); cell refinement: SAINT (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wiscosin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]).

Supporting information


Comment top

Pyrazoles are an important class of heterocyclic compounds and many pyrazole derivatives have a broad spectrum of biological activities such as anti-inflammatory (Singh et al., 1978; Tewari & Mishra, 2001), anti-viral (Genin et al., 2000; Storer et al., 1999), anti-tumor (Hsu et al., 1956; Skipper et al., 1955), and herbicidal (Jung et al., 2002; Kudo et al., 1999) activities. Recently urea derivatives of pyrazole been reported as potent inhibitors of P38 kinase (Duma, 2000), On the other hand, pyrazole derivatives are anti-angiogenic agent (Qiao et al., 2003), A3 adenosine receptor antagonist (Baraldi et al., 2003), neuropeptide YY5 receptor antagonists (Stamford & Wu, 2004) and kinase inhibitor for the treatment of type 2 diabetes, hyperlipidemia and obesity (Brown et al., 2004) as well as thrombopiotinmimetics (Heerding, 2003). Since the high electronegativity of halogens (particularly chlorine and fluorine) in the aromatic part of the drug molecules play an important role in enhancing their biological activity, we are interested to have 4-fluoro and 4-chloro substituted phenyl rings in the aromatic part of a 1,5-diaryl pyrazole. As part of our on going research programme aiming at the synthesis of new anti-microbial compounds, herein we report the crystal structure of a novel pyrazole derivative.

In the crystal structure (Fig. 1), the pyrazole ring system (C7/C8/N2/N1/C11) is approximately planar, with a maximum deviation of 0.002 (2) Å for atom C11. The dihedral angle formed between the mean plane of pyrazole ring and the benzene ring (C1–C6) is 66.93 (9)°. The bond lengths (Allen et al., 1987) and angles are within normal ranges and comparable to a closely related structure (Goh et al., 2009).

In the crystal packing (Fig. 2), pairs of intermolecular N2—H1N2···O2i and O3—H1O3···N1ii hydrogen bonds (Table 1) connect neighbouring molecules, into dimers, generating R22(10) and R22(8) ring motifs (Bernstein et al., 1995), respectively. The crystal structure is further stabilized by C—H···π interactions (Table 1), involving the C1–C6 (centroid Cg1) benzene ring.

Related literature top

For the biological activity of pyrazoles, see: Genin et al. (2000); Hsu et al. (1956); Jung et al. (2002); Kudo et al. (1999); Singh et al. (1978); Skipper et al. (1955); Storer et al. (1999); Tewari & Mishra (2001). For pyrazole derivatives, see: Baraldi et al. (2003); Brown et al. (2004); Duma et al. (2000); Heerding (2003); Qiao et al. (2003); Stamford & Wu (2004). For a related structure, see: Goh et al. (2009). For hydrogen-bond motifs, see: Bernstein et al. (1995). For bond-length data, see: Allen et al. (1987). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986). Cg1 is the centroid of the C1–C6 benzene ring.

Experimental top

LiHMDS (19.4 ml, 1.0 min THF, 19.4 mmol) was added quickly to the solution of oxyacetic acid ethyl ester (1.0 g, 5.5 mmol) in toluene (15.0 ml) using syringe at 195 K with agitation and the anion formed was allowed to stand for approximately 1 min, and then 2-methoxyacetyl chloride (1.0 ml, 13.8 mmol) was added into the lot with stirring. Reaction mixture was removed from acetone-dry ice bath and stirred for 10 min then acetic acid (2.0 ml) was added with stirring. Ethanol (15.0 ml) and hydrazine hydrate (1.5 ml, 44.0 mmol) was added and refluxed for 10 min. Reaction mixture was concentrated to dryness under reduced pressure and redissolved in ethyl acetate. The organic layer was washed with saturated brine solution, dried over Na2SO4 and evaporated under reduced pressure. Crude product was purified by column chromatography using a mixture of 1:99 methanol and ethylacetate. Pale yellow solid was obtained. Mp. 418.8–419.8 K. Yield: 57%.

Refinement top

All hydrogen atoms were located in a difference map and were refined freely. [Range of C—H = 0.94 (2)–1.03 (2) Å].

Computing details top

Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT (Bruker, 2005); data reduction: SAINT (Bruker, 2005); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).

Figures top
[Figure 1] Fig. 1. The molecular structure of the title compound, showing 50% probability displacement ellipsoids and the atom numbering scheme.
[Figure 2] Fig. 2. The crystal packing of the title compound, viewed along a axis. Intermolecular hydrogen bonds are shown by dashed lines.
5-Methoxymethyl-4-phenoxy-1H-pyrazol-3-ol top
Crystal data top
C11H12N2O3F(000) = 464
Mr = 220.23Dx = 1.355 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 6087 reflections
a = 8.8876 (5) Åθ = 2.3–32.2°
b = 10.3031 (5) ŵ = 0.10 mm1
c = 12.0083 (6) ÅT = 100 K
β = 100.917 (3)°Plate, yellow
V = 1079.7 (1) Å30.69 × 0.57 × 0.18 mm
Z = 4
Data collection top
Bruker SMART APEXII CCD area-detector
diffractometer
3433 independent reflections
Radiation source: fine-focus sealed tube2373 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.032
ϕ and ω scansθmax = 31.0°, θmin = 2.3°
Absorption correction: multi-scan
(SADABS; Bruker, 2005)
h = 1211
Tmin = 0.934, Tmax = 0.983k = 1414
14470 measured reflectionsl = 1717
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.058Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.138All H-atom parameters refined
S = 1.10 w = 1/[σ2(Fo2) + (0.0465P)2 + 0.7446P]
where P = (Fo2 + 2Fc2)/3
3433 reflections(Δ/σ)max < 0.001
193 parametersΔρmax = 0.45 e Å3
0 restraintsΔρmin = 0.33 e Å3
Crystal data top
C11H12N2O3V = 1079.7 (1) Å3
Mr = 220.23Z = 4
Monoclinic, P21/cMo Kα radiation
a = 8.8876 (5) ŵ = 0.10 mm1
b = 10.3031 (5) ÅT = 100 K
c = 12.0083 (6) Å0.69 × 0.57 × 0.18 mm
β = 100.917 (3)°
Data collection top
Bruker SMART APEXII CCD area-detector
diffractometer
3433 independent reflections
Absorption correction: multi-scan
(SADABS; Bruker, 2005)
2373 reflections with I > 2σ(I)
Tmin = 0.934, Tmax = 0.983Rint = 0.032
14470 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0580 restraints
wR(F2) = 0.138All H-atom parameters refined
S = 1.10Δρmax = 0.45 e Å3
3433 reflectionsΔρmin = 0.33 e Å3
193 parameters
Special details top

Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
O10.79382 (13)0.20467 (12)0.25817 (9)0.0209 (3)
O20.84461 (13)0.54359 (11)0.06550 (11)0.0243 (3)
O30.86330 (14)0.01790 (11)0.10686 (10)0.0210 (3)
N10.97188 (15)0.15166 (12)0.01762 (11)0.0187 (3)
N20.98156 (16)0.28291 (13)0.03420 (12)0.0197 (3)
C10.5751 (2)0.2793 (2)0.32287 (16)0.0313 (4)
C20.4180 (2)0.2854 (2)0.31444 (19)0.0373 (5)
C30.3212 (2)0.2243 (2)0.22663 (17)0.0315 (4)
C40.3817 (2)0.1569 (2)0.14638 (17)0.0339 (4)
C50.5396 (2)0.1508 (2)0.15308 (16)0.0293 (4)
C60.63487 (18)0.21173 (15)0.24200 (13)0.0182 (3)
C70.85883 (17)0.21114 (15)0.16285 (13)0.0178 (3)
C80.91537 (18)0.32155 (15)0.12032 (13)0.0188 (3)
C90.9123 (2)0.46065 (16)0.15618 (14)0.0222 (3)
C100.6866 (2)0.51602 (19)0.02363 (19)0.0310 (4)
C110.89717 (17)0.10779 (15)0.09653 (13)0.0177 (3)
H1A0.644 (3)0.324 (2)0.3821 (19)0.042 (6)*
H2A0.375 (3)0.334 (3)0.368 (2)0.056 (8)*
H3A0.214 (3)0.227 (2)0.2222 (19)0.039 (6)*
H4A0.315 (3)0.112 (3)0.087 (2)0.050 (7)*
H5A0.583 (2)0.106 (2)0.0976 (18)0.033 (6)*
H9A1.017 (2)0.4927 (19)0.1791 (16)0.021 (5)*
H9B0.853 (2)0.466 (2)0.2184 (17)0.028 (5)*
H10A0.678 (2)0.428 (2)0.0107 (19)0.038 (6)*
H10B0.652 (3)0.582 (3)0.032 (2)0.047 (7)*
H10C0.625 (3)0.518 (2)0.088 (2)0.041 (6)*
H1N21.038 (2)0.329 (2)0.0073 (17)0.024 (5)*
H1O30.924 (3)0.065 (2)0.067 (2)0.047 (7)*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
O10.0193 (5)0.0261 (6)0.0184 (5)0.0006 (5)0.0062 (4)0.0018 (4)
O20.0232 (6)0.0139 (6)0.0362 (7)0.0005 (4)0.0070 (5)0.0036 (5)
O30.0265 (6)0.0133 (5)0.0264 (6)0.0028 (5)0.0134 (5)0.0010 (4)
N10.0228 (7)0.0116 (6)0.0232 (6)0.0002 (5)0.0081 (5)0.0000 (5)
N20.0233 (7)0.0131 (6)0.0246 (7)0.0006 (5)0.0091 (5)0.0009 (5)
C10.0302 (9)0.0340 (11)0.0320 (9)0.0006 (8)0.0114 (7)0.0121 (8)
C20.0321 (10)0.0416 (12)0.0431 (11)0.0074 (9)0.0194 (9)0.0070 (9)
C30.0215 (8)0.0372 (11)0.0378 (10)0.0046 (8)0.0110 (7)0.0117 (8)
C40.0228 (9)0.0446 (12)0.0332 (10)0.0023 (8)0.0027 (7)0.0019 (9)
C50.0236 (9)0.0364 (11)0.0286 (9)0.0012 (7)0.0065 (7)0.0094 (8)
C60.0198 (7)0.0143 (7)0.0220 (7)0.0012 (6)0.0080 (6)0.0024 (6)
C70.0187 (7)0.0175 (7)0.0178 (7)0.0007 (6)0.0051 (5)0.0002 (6)
C80.0191 (7)0.0154 (7)0.0218 (7)0.0013 (6)0.0038 (6)0.0012 (6)
C90.0254 (8)0.0153 (8)0.0263 (8)0.0004 (6)0.0056 (6)0.0022 (6)
C100.0238 (9)0.0213 (9)0.0462 (11)0.0011 (7)0.0020 (8)0.0031 (8)
C110.0181 (7)0.0159 (7)0.0198 (7)0.0007 (6)0.0054 (5)0.0001 (6)
Geometric parameters (Å, º) top
O1—C71.3781 (18)C3—C41.377 (3)
O1—C61.3910 (19)C3—H3A0.94 (2)
O2—C91.425 (2)C4—C51.392 (3)
O2—C101.427 (2)C4—H4A0.96 (3)
O3—C111.3406 (19)C5—C61.382 (2)
O3—H1O30.92 (3)C5—H5A0.95 (2)
N1—C111.335 (2)C7—C81.380 (2)
N1—N21.3672 (19)C7—C111.410 (2)
N2—C81.343 (2)C8—C91.498 (2)
N2—H1N20.91 (2)C9—H9A0.98 (2)
C1—C61.380 (2)C9—H9B0.99 (2)
C1—C21.383 (3)C10—H10A0.99 (2)
C1—H1A0.96 (2)C10—H10B0.96 (3)
C2—C31.380 (3)C10—H10C1.03 (2)
C2—H2A0.95 (3)
C7—O1—C6117.13 (12)C1—C6—O1116.36 (15)
C9—O2—C10113.24 (13)C5—C6—O1122.80 (14)
C11—O3—H1O3107.0 (15)O1—C7—C8125.92 (14)
C11—N1—N2104.93 (13)O1—C7—C11128.09 (14)
C8—N2—N1112.37 (13)C8—C7—C11105.64 (14)
C8—N2—H1N2129.8 (13)N2—C8—C7106.50 (14)
N1—N2—H1N2117.5 (13)N2—C8—C9122.63 (14)
C6—C1—C2119.29 (18)C7—C8—C9130.87 (15)
C6—C1—H1A119.0 (14)O2—C9—C8112.47 (13)
C2—C1—H1A121.7 (14)O2—C9—H9A104.7 (11)
C3—C2—C1120.65 (18)C8—C9—H9A109.7 (11)
C3—C2—H2A119.0 (16)O2—C9—H9B109.6 (12)
C1—C2—H2A120.3 (16)C8—C9—H9B107.9 (12)
C4—C3—C2119.72 (17)H9A—C9—H9B112.5 (16)
C4—C3—H3A119.8 (14)O2—C10—H10A108.6 (13)
C2—C3—H3A120.5 (14)O2—C10—H10B105.4 (14)
C3—C4—C5120.34 (18)H10A—C10—H10B111.7 (19)
C3—C4—H4A119.9 (15)O2—C10—H10C111.1 (13)
C5—C4—H4A119.7 (15)H10A—C10—H10C108.8 (18)
C6—C5—C4119.20 (17)H10B—C10—H10C111.3 (19)
C6—C5—H5A119.6 (13)N1—C11—O3122.92 (14)
C4—C5—H5A121.2 (13)N1—C11—C7110.57 (14)
C1—C6—C5120.79 (16)O3—C11—C7126.51 (14)
C11—N1—N2—C80.09 (17)N1—N2—C8—C9179.33 (14)
C6—C1—C2—C30.3 (3)O1—C7—C8—N2173.96 (14)
C1—C2—C3—C40.2 (3)C11—C7—C8—N20.26 (17)
C2—C3—C4—C50.4 (3)O1—C7—C8—C95.4 (3)
C3—C4—C5—C60.9 (3)C11—C7—C8—C9179.12 (16)
C2—C1—C6—C50.2 (3)C10—O2—C9—C864.02 (19)
C2—C1—C6—O1177.32 (17)N2—C8—C9—O256.1 (2)
C4—C5—C6—C10.7 (3)C7—C8—C9—O2124.58 (18)
C4—C5—C6—O1176.57 (17)N2—N1—C11—O3179.16 (14)
C7—O1—C6—C1142.80 (16)N2—N1—C11—C70.26 (17)
C7—O1—C6—C539.8 (2)O1—C7—C11—N1173.85 (14)
C6—O1—C7—C895.50 (18)C8—C7—C11—N10.33 (18)
C6—O1—C7—C1192.22 (19)O1—C7—C11—O37.3 (3)
N1—N2—C8—C70.12 (18)C8—C7—C11—O3179.19 (15)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N2—H1N2···O2i0.91 (2)1.89 (2)2.7778 (18)165.7 (19)
O3—H1O3···N1ii0.92 (2)1.74 (2)2.6663 (18)176 (2)
C3—H3A···Cg1iii0.94 (2)2.77 (3)2.73147.6 (18)
Symmetry codes: (i) x+2, y+1, z; (ii) x+2, y, z; (iii) x1, y, z.

Experimental details

Crystal data
Chemical formulaC11H12N2O3
Mr220.23
Crystal system, space groupMonoclinic, P21/c
Temperature (K)100
a, b, c (Å)8.8876 (5), 10.3031 (5), 12.0083 (6)
β (°) 100.917 (3)
V3)1079.7 (1)
Z4
Radiation typeMo Kα
µ (mm1)0.10
Crystal size (mm)0.69 × 0.57 × 0.18
Data collection
DiffractometerBruker SMART APEXII CCD area-detector
diffractometer
Absorption correctionMulti-scan
(SADABS; Bruker, 2005)
Tmin, Tmax0.934, 0.983
No. of measured, independent and
observed [I > 2σ(I)] reflections
14470, 3433, 2373
Rint0.032
(sin θ/λ)max1)0.725
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.058, 0.138, 1.10
No. of reflections3433
No. of parameters193
H-atom treatmentAll H-atom parameters refined
Δρmax, Δρmin (e Å3)0.45, 0.33

Computer programs: APEX2 (Bruker, 2005), SAINT (Bruker, 2005), SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).

Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N2—H1N2···O2i0.91 (2)1.89 (2)2.7778 (18)165.7 (19)
O3—H1O3···N1ii0.92 (2)1.74 (2)2.6663 (18)176 (2)
C3—H3A···Cg1iii0.94 (2)2.77 (3)2.73147.6 (18)
Symmetry codes: (i) x+2, y+1, z; (ii) x+2, y, z; (iii) x1, y, z.
 

Footnotes

Thomson Reuters ResearcherID: A-3561-2009.

Acknowledgements

HKF and TSH thank Universiti Sains Malaysia (USM) for the Research University Golden Goose Grant (1001/PFIZIK/811012). VV is grateful to the DST-India for funding through the Young Scientist Scheme (Fast Track Proposal).

References

First citationAllen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1–19.  CrossRef Web of Science Google Scholar
First citationBaraldi, P. G., Bovero, A., Fruttarolo, F., Romagnoli, R., Tabrizi, M. A., Preti, D., Varani, K., Borea, P. A. & Moorman, A. R. (2003). Bioorg. Med. Chem. 11, 4161–4169.  Web of Science CrossRef PubMed CAS Google Scholar
First citationBernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573.  CrossRef CAS Web of Science Google Scholar
First citationBrown, M. L., Cheung, M., Dickerson, S. H., Drewy, D. H., Lackey, K. E., Peat, A. J., Thomson, S. A., Veal, J. M. & Wilson, J. L. R. (2004). PCT Int. Appl. WO 20049596.  Google Scholar
First citationBruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wiscosin, USA.  Google Scholar
First citationCosier, J. & Glazer, A. M. (1986). J. Appl. Cryst. 19, 105–107.  CrossRef CAS Web of Science IUCr Journals Google Scholar
First citationDuma, J., Hatoum-Mokdad, H., Sibley, R., Riedl, B., Scott, W. J., Monahan, M. K., Lowinger, T. B., Brennan, C., Natero, R., Turner, T., Johnson, J. S., Schoenlebar, R., Bhargava, A., Wilhelm, S. M., Housley, T. J., Ranges, G. E. & Shrikhande, A. (2000). Bioorg. Med. Chem. Lett. 10, 2051–2054.  Web of Science PubMed Google Scholar
First citationGenin, M. J., Biles, C., Keiser, B. J., Poppe, S. M., Swaney, S. M., Tarpley, W. G., Yagi, Y. & Romero, D. L. (2000). J. Med. Chem. 43, 1034–1040.  Web of Science CrossRef PubMed CAS Google Scholar
First citationGoh, J. H., Fun, H.-K., Nithinchandra, & Kalluraya, B. (2009). Acta Cryst. E65, o3088–o3089.  Google Scholar
First citationHeerding, D. A. (2003). PCT Int. Appl. WO, 2003103686.  Google Scholar
First citationHsu, T. C., Robins, R. K. & Cheng, C. C. (1956). Science, 13, 848–868.  CrossRef Web of Science Google Scholar
First citationJung, J. C., Walkins, E. B. & Avery, M. A. (2002). Tetrahedron, 58, 3039–3049.  Web of Science CrossRef Google Scholar
First citationKudo, N., Furuta, S., Taniguchi, M., Endo, T. & Sato, K. (1999). Chem. Pharm. Bull. 47, 857–868.  CrossRef CAS Google Scholar
First citationQiao, J. X., Pinto, D. J., Orwat, M. J., Han, W. & Friedrich, S. R. (2003). PCT Int. Appl. WO, 200399276.  Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationSingh, S. P., Prakash, O., Tomer, R. K. & Sawhney, S. N. (1978). Indian J. Chem. Sect. B, 16, 733–735.  Google Scholar
First citationSkipper, H. E., Robins, R. K. & Thompson, J. R. (1955). Proc. Soc. Exp. Bio. Med. 89, 589–594.  CrossRef Google Scholar
First citationSpek, A. L. (2009). Acta Cryst. D65, 148–155.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationStamford, A. W. & Wu, Y. (2004). PCT Int. Appl. WO 20045262.  Google Scholar
First citationStorer, R., Ashton, C. J., Baxter, A. D., Hann, M. M., Marr, C. L. P., Mason, A. M., Mo, C. L., Myers, P. L., Noble, S. A., Penn, H. R., Weir, N. G., Niall, G., Woods, J. M. & Coe, P. L. (1999). Nucleosides Nucleotides, 18, 203–216.  Web of Science CrossRef PubMed CAS Google Scholar
First citationTewari, A. K. & Mishra, A. (2001). Bioorg. Med. Chem. 9, 715–718.  Web of Science CrossRef PubMed CAS Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 65| Part 12| December 2009| Pages o3249-o3250
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds